Words matter: Stigmatizing language in medical records of individuals electing medication for opioid use disorder
Matthew Perez1, Elise N Marino2, Curtis Bone3
1Be Well Institute on Substance Use and Related Disorders, University of Texas Health Science Center at San Antonio, 5109 Medical Drive, MC8350, San Antonio, TX 78229, USA.
Background:
There has been a concerted effort to minimize the use of stigmatizing language in healthcare settings; however, its prevalence in health record documentation remains high. This study examined clinicians' stigmatizing and patients' self-stigmatizing language in medical records for patients electing medication for opioid use disorder in two settings, office-based opioid treatment and opioid treatment programs.
Methods:
In this retrospective cohort study, data were extracted from health records for a distributed provider network serving publicly funded patients in Texas. Patients seeking medication treatment for opioid use disorder between December 2020 and November 2021 were included. Using a natural language processing algorithm to review open text fields in the health records, we identified the prevalence of stigmatizing language identified in the National Institute on Drug Abuse's "Words Matter" tool.
Results:
The analytic sample included 1391 patients (63.8 % White, 27.5 % Hispanic, 40.5 % female, Mage= 40.8 years [SD=10.3]). Of the 6099 notes analyzed, 81.1 % (n = 4944) contained stigmatizing language and 7.1 % (n = 430) contained self-stigmatizing language. In multivariate models, stigmatizing language was associated with age, race, rurality, education, income, opioid use, and treatment setting. Self-stigmatizing language was associated with treatment setting.
Conclusions:
Findings suggest that a patient's sociodemographic background influences the stigmatizing language their clinicians use while treatment setting influences both provider and self-stigmatizing language. Additional research is needed to explore whether differences in stigmatizing language contributes to differential treatment outcomes seen in different opioid treatment settings.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Nomenclature
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Dependence
